Preferred Label : alfacalcidol;
MeSH note : RN refers to (1alpha,3beta,5Z,7E)-isomer; a vitamin D analog;
CISMeF synonym : APS brand of alfacalcidol; AlfaD; bondiol; byk tosse brand of alfacalcidol; doss brand of alfacalcidol; eenalfadrie; etalpha; farmacusi brand of alfacalcidol; gry brand of alfacalcidol; leo brand of alfacalcidol; oksidevit; teva brand of alfacalcidol;
MeSH synonym : 1 alpha-hydroxycholecalciferol; 1alpha-OHD3; 1 alpha-hydroxyvitamin D3; alphacalcidol; 1-alpha-oxycholecalciferol; 1-hydroxycholecalciferol;
MeSH hyponym : Un-Alfa; EinsAlpha; One-Alpha;
MeSH CAS label : 9,10-secocholesta-,7,10(19)-triene-1 alpha,3 beta-diol;
MeSH Related Number : 1-hydroxycholecalciferol, (1alpha,3alpha-(5Z,7E))-isomer; 1-hydroxycholecalciferol, (1beta)-(5Z)-isomer; 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer; 1-hydroxycholecalciferol, aluminum salt; 41294-56-8 (alfacalcidol); 58028-00-5 ((1alpha,3alpha-(5Z,7E))-isomer); 63181-13-5 ((1beta)-(5Z)-isomer); 65119-86-0 (Al salt); 65445-15-0 ((1beta,3beta-(5E,7E))-isomer);
Registry Number MeSH : 41294-56-8;
Related CAS MeSH : 58028-00-5 (1-hydroxycholecalciferol, (1alpha,3alpha-(5Z,7E))-isomer); 63181-13-5 (1-hydroxycholecalciferol, (1beta)-(5Z)-isomer); 65445-15-0 (1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer); 65119-86-0 (1-hydroxycholecalciferol, aluminum salt);
related registry number list (CISMeF) : 58028-00-5 ((1alpha,3alpha-(5Z,7E))-isomer); 63181-13-5 ((1beta)-(5Z)-isomer); 65119-86-0
(Al salt); 65445-15-0 ((1beta,3beta-(5E,7E))-isomer);
Codes EINECS : 255-297-1;
Is substance : O;
UNII : URQ2517572;
InChIKey : OFHCOWSQAMBJIW-AVJTYSNKSA-N;
Origin ID : C008088;
UMLS CUI : C0044410;
ATC code(s)
CISMeF manual mappings
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3149204/fr/un-alfa
2020
false
false
false
France
alfacalcidol
treatment outcome
insurance, health, reimbursement
alfacalcidol
evaluation of the transparency committee
hydroxycholecalciferols
---
http://www.has-sante.fr/portail/jcms/c_2045290/fr/un-alfa
2015
true
France
French
evaluation of the transparency committee
Late neonatal hypocalcemia (disorder)
hydroxycholecalciferols
alfacalcidol
administration, oral
hydroxycholecalciferols
alfacalcidol
insurance, health, reimbursement
rickets
Chronic Kidney Disease-Mineral and Bone Disorder
Chronic Kidney Disease-Mineral and Bone Disorder
familial hypophosphatemic rickets
hypoparathyroidism
pseudohypoparathyroidism
hypocalcemia
---
http://www.has-sante.fr/portail/jcms/c_2572169/fr/alfacalcidol-teva
2015
false
false
false
France
French
evaluation of the transparency committee
alfacalcidol
hydroxycholecalciferols
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64661847
2012
France
summary of product characteristics
package leaflet
capsules
alfacalcidol
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62626139
2012
France
summary of product characteristics
package leaflet
capsules
alfacalcidol
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/alfacalcidol_-_ct-_10379.pdf
http://www.has-sante.fr/portail/jcms/c_1054883/alfacalcidol-teva
2011
France
French
evaluation of the transparency committee
hydroxycholecalciferols
alfacalcidol
administration, oral
hydroxycholecalciferols
alfacalcidol
insurance, health, reimbursement
rickets
Chronic Kidney Disease-Mineral and Bone Disorder
Chronic Kidney Disease-Mineral and Bone Disorder
familial hypophosphatemic rickets
hypoparathyroidism
pseudohypoparathyroidism
hypocalcemia
---